Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Bio-IT World Conference & Expo in Boston, which runs May 15 to 18. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, entitled “Can AI Beat Cancer?“: AI can beat go and drive cars, but can… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak next week at the Bridging Clinical Research & Clinical Health Care Collaborative in National Harbor, Maryland. His presentation will be featured in a session focused on precision oncology, which runs from 3:30 to 5:00 pm on Wednesday April 4. The Bridging Clinical Research & Clinical Health Care Collaborative is “the only forum where clinical research and health care… Read more »
A presentation by Cancer Commons founder Marty Tenenbaum, PhD, was well-received last month at the Precision Medicine World Conference (PMWC) in Silicon Valley. His talk, “How AI will Cure Cancer,” discussed the role of artificial intelligence in finding better cancer treatments. In a separate event at the same conference, Cancer Commons medical director Kevin Knopf, MD, spoke about the future of personalized medicine as part of a panel… Read more »
Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valley, which runs Jan 22–24. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the potential for artificial intelligence to help find better cancer treatments. Read the synopsis of Marty’s presentation, entitled “How AI will Cure Cancer”: From an AI perspective, finding effective treatments for cancer… Read more »
In a new guest blog post for CollabRx, Cancer Commons scientist and project manager Lisandra West-Odell discusses how we’re harnessing the power of data analytics to improve treatment for cancer patients, starting with brain cancer: “I am reminded of the old adage: ‘Lessons come from the journey, not the destination.’ Where one patient’s story can only exist as an anecdote, many stories can be… Read more »
Hear from some more cancer fighters: Avid @ArizonaCoyotes fan Tom (Labonte) from Chandler and @judefox10 #YotesFightCancer pic.twitter.com/LVlQ0Z7NW0 — FOX Sports Arizona (@FOXSPORTSAZ) November 5, 2017 Fox 10 News sports anchor Jude LaCava is a long-time proponent of Cancer Commons who has sent many patients and caregivers our way to receive extra guidance for their cancer treatment, including Super Patient Mary Beth Smith. This past weekend,… Read more »
We at Cancer Commons express our deep gratitude to the H8 Cancer Foundation, which has generously made our organization a major beneficiary of its gifts since 2015. Founded by oncologist Dr. Simeon Jaggernauth, H8 Cancer is “dedicated to raising funds for research and to promote awareness of better treatment options to save lives.” Recently, we had the honor of attending Tomstock, an annual summer music festival to benefit H8… Read more »
Cancer Commons founder Marty Tenenbaum wrote a letter to the editor that has now been published in The Economist. His piece discusses the importance of using data to accelerate improvement of cancer treatment. From the letter: “The oncology drug pipeline is full of promising immunotherapies and targeted treatments (Technology Quarterly on cancer, September 16th). Unfortunately, no one knows the optimal way to use them. Doctors and patients… Read more »
A little more than four years ago, longtime friends Tom and Carman Duvall, and Kiers and Steve Rowley reminisced at dinner about their lives in the 1980s, long before their schedules had grown complicated and filled with endless trips driving children to various activities. Tom, a child of 1980s rock and roll, wondered aloud whether Def Leppard might perform for them on his next… Read more »
In 2014, a dedicated team of Deloitte colleagues joined forces to help cancer patients find the best treatment options for optimal outcomes. They made their first gifts to Cancer Commons in memory of Jackie Tran. Ms. Tran was a Deloitte partner who received support from Cancer Commons’ ASK service while navigating her treatment options for ovarian cancer. Since then, over $300,000 has been raised… Read more »